Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity
Editor’s summary Vancomycin and its second-generation lipoglycopeptide derivatives work mainly by binding the peptidoglycan precursor lipid II to inhibit cell wall synthesis in Gram-positive bacteria.
